Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joakim Dillner

Showing results (1-10 of 471) with videos related to

Pageof 48
Sort By:
Lakartidningen|July 10, 2002
[The new biobank law accepted: a unique chance of improvement]Joakim Dillner
The Lancet. Infectious Diseases|February 13, 2019
Some clear answers regarding transmission of genital human papillomavirusJoakim Dillner
Molecular Oncology|January 25, 2019
Early detection and preventionJoakim Dillner
Lakartidningen|November 25, 2003
[Testing HPV vaccine is an ethical dilemma. Can we afford not to offer vaccination against an infection which is a cause of cancer?]Joakim Dillner
Current Topics in Microbiology and Immunology|February 15, 2026
Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus GenotypesJoakim Dillner
Current Opinion in Obstetrics & Gynecology|January 10, 2013
Primary human papillomavirus testing in organized cervical screeningJoakim Dillner
Lakartidningen|December 10, 2002
[The survey of Danish biobanks suggests a "drop-out" registry]Joakim Dillner
Clinical Chemistry|September 29, 2005
Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysisJoakim Dillner
Seminars in Oncology|April 7, 2015
Prevention of human papillomavirus-associated cancersJoakim Dillner
Journal of Medical Virology|January 18, 2024
Nobel calling Harald zur HausenJoakim Dillner
Pageof 48

Showing results (1-10 of 471) with videos related to

Sort By:
Pageof 48
Lakartidningen|July 10, 2002
[The new biobank law accepted: a unique chance of improvement]Joakim Dillner
The Lancet. Infectious Diseases|February 13, 2019
Some clear answers regarding transmission of genital human papillomavirusJoakim Dillner
Molecular Oncology|January 25, 2019
Early detection and preventionJoakim Dillner
Lakartidningen|November 25, 2003
[Testing HPV vaccine is an ethical dilemma. Can we afford not to offer vaccination against an infection which is a cause of cancer?]Joakim Dillner
Current Topics in Microbiology and Immunology|February 15, 2026
Human Papillomavirus Screening: Design and Targeting of Human Papillomavirus GenotypesJoakim Dillner
Current Opinion in Obstetrics & Gynecology|January 10, 2013
Primary human papillomavirus testing in organized cervical screeningJoakim Dillner
Lakartidningen|December 10, 2002
[The survey of Danish biobanks suggests a "drop-out" registry]Joakim Dillner
Clinical Chemistry|September 29, 2005
Toward "serolomics": papillomavirus serology is taking a technologic lead in high-throughput multiplexed antibody analysisJoakim Dillner
Seminars in Oncology|April 7, 2015
Prevention of human papillomavirus-associated cancersJoakim Dillner
Journal of Medical Virology|January 18, 2024
Nobel calling Harald zur HausenJoakim Dillner
Pageof 48